BG101173A - Vaccine against pasteurellosis and haemorrhagic disease in rabbits - Google Patents

Vaccine against pasteurellosis and haemorrhagic disease in rabbits

Info

Publication number
BG101173A
BG101173A BG101173A BG10117397A BG101173A BG 101173 A BG101173 A BG 101173A BG 101173 A BG101173 A BG 101173A BG 10117397 A BG10117397 A BG 10117397A BG 101173 A BG101173 A BG 101173A
Authority
BG
Bulgaria
Prior art keywords
rabbits
vaccine against
haemorrhagic disease
against pasteurellosis
pasteurellosis
Prior art date
Application number
BG101173A
Other languages
Bulgarian (bg)
Other versions
BG63033B1 (en
Inventor
Марин Петков
Мария Никифорова
Райко Пешев
Бойко Митов
Хараламби Хараламбиев
Original Assignee
Научно-Изследов. Произв. Ветеринарно-Медицински Институт По Имунология
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Научно-Изследов. Произв. Ветеринарно-Медицински Институт По Имунология filed Critical Научно-Изследов. Произв. Ветеринарно-Медицински Институт По Имунология
Priority to BG101173A priority Critical patent/BG63033B1/en
Publication of BG101173A publication Critical patent/BG101173A/en
Publication of BG63033B1 publication Critical patent/BG63033B1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The vaccination is used in veterinary medicine for preventingrabbits from haemorrahagic disease and pasteurellosis. Thevaccinal antigens of the vaccine are activated and stabilized bytheir treatment with trypsin.1 claim
BG101173A 1997-01-27 1997-01-27 Biocomponent vaccine against pasteurellosis and haemorrhagic disease in rabbits BG63033B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BG101173A BG63033B1 (en) 1997-01-27 1997-01-27 Biocomponent vaccine against pasteurellosis and haemorrhagic disease in rabbits

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BG101173A BG63033B1 (en) 1997-01-27 1997-01-27 Biocomponent vaccine against pasteurellosis and haemorrhagic disease in rabbits

Publications (2)

Publication Number Publication Date
BG101173A true BG101173A (en) 1998-10-30
BG63033B1 BG63033B1 (en) 2001-02-28

Family

ID=3926850

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101173A BG63033B1 (en) 1997-01-27 1997-01-27 Biocomponent vaccine against pasteurellosis and haemorrhagic disease in rabbits

Country Status (1)

Country Link
BG (1) BG63033B1 (en)

Also Published As

Publication number Publication date
BG63033B1 (en) 2001-02-28

Similar Documents

Publication Publication Date Title
EP2270046A3 (en) Methods and compositions for the treatment of hemolysis-associated diseases
LV12438A (en) Metode of preventing and delyaing the onset of alzheimer's disease and composition thereof
KR970704430A (en) USE OF DROLOXIFENE FOR THE TREATMENT OF PROSTATIC DISEASES ENDOMETRIOSIS AND OBESITY
KR970704410A (en) Implanted Device Containing Tumor Cells for the Treatment of Cancer
HU9602937D0 (en) Compositions comprising dna damaging agents and p53
FR2726191B1 (en) DEVICE FOR THE TREATMENT OF APNEA SYNDROME DURING SLEEP
GB9609932D0 (en) Use of IL-12 and IFN alpha for the treatment of infectious diseases
ATE255128T1 (en) PEPTIDE-IMMITTING SUBSTANCES IN CANCER THERAPY
GR3035440T3 (en) Therapeutic uses of bpi protein products for human meningococcemia
EP0245433A4 (en) Major iron-regulated protein of neisseria gonorrhoeae and its use as vaccine.
ATE247709T1 (en) 3'UTR OF THE HUMAN PROHIBITIN GENE
HUT73215A (en) Recombinant adenoviruses and use thereof in gene therapy
HU9600887D0 (en) Compounds for medicinal use
EP0173663A3 (en) The use of a specific tumor associated antigen, sialosyllactotetraose, in diagnostic or therapeutic procedures related to cancer deseases
IL127739A0 (en) Retinoyloxy (substituted) alkylene butyrates useful for the treatment of cancer and other proliferative diseases
FI973185A0 (en) Use of melatonin in the treatment of patients with drug dependence
BG101173A (en) Vaccine against pasteurellosis and haemorrhagic disease in rabbits
GEP20012489B (en) Use of Natural Human α-Interferon
DE69128385T2 (en) Rubber composition and article for pharmaceuticals and medical treatment systems
GR3005231T3 (en)
MY103584A (en) 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it
IT234199Y1 (en) VAGINAL CANNULA, PARTICULARLY DESIGNED FOR THE USE OF POMATE AND MEDICAMENTOUS PRODUCTS IN GENERAL
九嶋亮治 Characteristics of human gastric cancer tissues and their alteration with tumor progression.
NZ333652A (en) Inhibition of human rotavirus infection using kappa-casein
Goodnough Mechanisms of action of selected drug therapies used in the treatment of refractory depression